Liso-Cel CAR-T cell therapy approved for relapsed/refractory follicular lymphoma in the EU and UK
In recent weeks there have been a number of announcements regarding an alternative treatment option now being available for adults with relapsed/ refractory indolent follicular lymphoma (FL) across the EU and transformed follicular lymphoma within the UK.
FLF seeks an enthusiastic and entrepreneurial Senior Director of Major Gifts (Senior Director)
FLF seeks an enthusiastic and entrepreneurial Senior Director of Major Gifts (Senior Director) to foster the growth of the organization’s United States-based fundraising program. The ideal candidate will embody the organization’s mission to the United States philanthropic community and carry a portfolio of major gifts prospects and donors, with responsibility for creating constituency and growth in FLF’s United States donor pipeline.
Two new ASPIRE awards target Biomarker Discovery in Follicular Lymphoma
The Mark Foundation for Cancer Research and the Follicular Lymphoma Foundation have joined forces to co-fund two new ASPIRE Awards focused on developing more personalized treatment strategies for FL.
Webinar: When FL Changes: Understanding Progression & Transformation (new date 28.4.25)
Join us for an informative webinar where expert clinicians and individuals living with FL come together to explore understanding the signs, treatment options, and what to expect.
Whether you’re navigating FL yourself, supporting or caring for a loved one, this session will provide vital knowledge, expert guidance, and a personal story of resilience.
Insights and Impact: The FLF at ASH Annual Meeting 2024, San Diego
The Follicular Lymphoma Foundation (FLF) was thrilled to participate in the recent American Society of Hematology (ASH) Annual Meeting.
Welcoming Emma France as FLF’s New Global CEO
The FLF welcomes Emma France as our new Global CEO. With over 20 years of non-profit leadership, Emma will help drive our mission forward with bold action and impactful change.
FLF’s CMO Shares Key Scientific Highlights from ASH 2024
FLF’s CMO highlights key takeaways from ASH 2024 on follicular lymphoma, from immunotherapy to new treatments.
World Cancer Day 2025: Supporting Follicular Lymphoma Patients
“Treat the person, not just the disease.”
World Cancer Day is on the 4th February. This year’s theme, United by Unique, emphasizes an essential shift in cancer care: putting patients at the heart of every decision.
2024 End of Year Reflections
This year has been transformative, marked by groundbreaking progress in our mission to cure follicular lymphoma.
Unlock the Cure Gala Dinner Raises Over £800,000
We are thrilled to announce that our Unlock the Cure Gala Dinner saw us raise an astounding £800,000 to further our mission of finding a cure for follicular lymphoma.